MONTUTAS-L TAB

Uses of MONTUTAS-L TAB

MONTUTAS-L TAB is indicated for the treatment and prevention of various allergic and respiratory conditions. It is particularly effective in managing symptoms associated with:

• Allergic Rhinitis

  This medication is used to relieve symptoms of seasonal and perennial allergic rhinitis, such as sneezing, runny nose, nasal congestion, and itchy or watery eyes. It helps reduce the inflammatory response triggered by allergens like pollen, dust mites, and pet dander, providing significant symptomatic relief and improving daily comfort.

• Asthma

  MONTUTAS-L TAB is prescribed for the prophylaxis and chronic treatment of asthma in adults and pediatric patients. It helps prevent asthma attacks, reduces the frequency and severity of symptoms like wheezing and shortness of breath, and improves lung function. It is particularly useful for exercise-induced bronchoconstriction and aspirin-sensitive asthma.

• Chronic Urticaria (Hives)

  The tablet is also effective in managing chronic idiopathic urticaria, a condition characterized by recurrent hives and itching without an identifiable cause. Levocetirizine's antihistaminic action helps alleviate the itching and reduces the size and number of hives, providing relief and improving skin comfort for affected individuals.

Side Effects of MONTUTAS-L TAB

Like all medicines, MONTUTAS-L TAB can cause side effects, although not everybody gets them. Most side effects are mild to moderate and temporary. Consult your doctor if any of these persist or worsen.

Less common or rare side effects may include:

If you experience any severe or unusual side effects, or if you notice any symptoms not listed here, seek immediate medical attention. Do not discontinue the medication without consulting your doctor.

How to use MONTUTAS-L TAB

• Adults:

  Typically, one tablet of MONTUTAS-L TAB (Montelukast 10mg + Levocetirizine 5mg) is taken once daily, preferably in the evening or at bedtime, with or without food. The tablet should be swallowed whole with water. Adhere strictly to the dosage and duration prescribed by your doctor.

• Children:

  For children aged 6-14 years, a lower strength tablet (Montelukast 5mg + Levocetirizine 2.5mg) is usually prescribed once daily, preferably in the evening. For younger children, liquid formulations may be available. Always consult a pediatrician for appropriate dosing based on age and weight.

• Elderly:

  No specific dose adjustment is generally required for elderly patients unless there is significant renal impairment. However, elderly patients may be more susceptible to side effects, so monitoring is advisable. Consult your doctor for personalized advice.

• Missed Dose:

  If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to compensate for a missed one, as this may increase the risk of side effects.

How MONTUTAS-L TAB works

MONTUTAS-L TAB combines two active ingredients, Montelukast and Levocetirizine, each with a distinct mechanism of action to provide synergistic relief. Montelukast is a selective and orally active leukotriene receptor antagonist. Leukotrienes are potent inflammatory mediators released from various cells, including mast cells and eosinophils, which contribute to the pathophysiology of asthma and allergic rhinitis. By binding to the CysLT1 receptor, Montelukast inhibits the actions of leukotrienes, thereby reducing bronchoconstriction, inflammation, and mucus secretion in the airways, and alleviating nasal congestion. Levocetirizine, on the other hand, is a third-generation non-sedating antihistamine. It selectively antagonizes peripheral H1-receptors, blocking the action of histamine, a primary mediator of allergic reactions. By inhibiting histamine, Levocetirizine effectively reduces symptoms like sneezing, itching, runny nose, and watery eyes associated with allergic rhinitis and chronic urticaria. The combination of these two agents provides a broader spectrum of action, addressing both the leukotriene and histamine-mediated inflammatory pathways, leading to more effective and sustained relief from allergic and asthmatic symptoms.

Precautions

• Inform your doctor about all your medical conditions, especially kidney or liver disease.
• Avoid driving or operating heavy machinery if you experience drowsiness or dizziness.
• Do not stop taking this medicine suddenly, especially if you are using it for asthma, without consulting your doctor.
• Report any changes in mood, behavior, or suicidal thoughts to your doctor immediately.
• Avoid alcohol consumption while on this medication as it may increase drowsiness.
• This medicine is not intended to treat acute asthma attacks; use your rescue inhaler for such episodes.

Safety Advice

Alcohol

UNSAFE

Consumption of alcohol with MONTUTAS-L TAB is unsafe. It can increase the risk of drowsiness, dizziness, and impaired concentration, making daily activities hazardous. It is best to avoid alcohol entirely during treatment.

Pregnancy

CONSULT YOUR DOCTOR

MONTUTAS-L TAB should be used during pregnancy only if clearly needed and after careful consideration of the benefits versus risks by a doctor. Limited data are available, so always consult your healthcare provider before use.

Breastfeeding

CONSULT YOUR DOCTOR

Both Montelukast and Levocetirizine are excreted in human milk. Therefore, MONTUTAS-L TAB should be used with caution in breastfeeding mothers. Discuss the potential risks and benefits with your doctor.

Driving

UNSAFE

MONTUTAS-L TAB can cause drowsiness, dizziness, and fatigue in some individuals. If you experience these symptoms, it is unsafe to drive or operate heavy machinery. Exercise caution until you know how the medicine affects you.

Kidney

CAUTION

Patients with kidney disease should use MONTUTAS-L TAB with caution. Dose adjustment may be necessary, especially in severe renal impairment. Regular monitoring of kidney function may be advised by your doctor.

Liver

CAUTION

Use MONTUTAS-L TAB with caution in patients with liver disease. While Montelukast is extensively metabolized by the liver, Levocetirizine is minimally metabolized. Dose adjustments might be required in severe hepatic impairment. Consult your doctor for guidance.

Fact Box

Frequently asked questions by patients

Frequently Asked Questions

Additional Information